Spotlight on Cancer: Genitourinary Cancer Research and The West Clinic
West Clinic Selected For International Trial Investigating Adjuvant Treatment of Renal Cell Carcinoma
The West Clinic has been selected to participate in a prestigious international clinical trial for the adjuvant treatment of renal cell carcinoma. The Phase 3 randomized, double-blind, placebo controlled trial will evaluate oral Sutent or placebo for one year of therapy in the adjuvant setting. The primary end point is disease-free survival. The West Clinic is one of a select few sites in the US selected to participate in the trial.
Brad S. Somer, MD |
|
